[HTML] sciencedirect.com

[HTML][HTML] Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment

ET Piperaki, LS Tzouvelekis, V Miriagou… - Clinical Microbiology and …, 2019 - Elsevier
Abstract Background Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained
global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated …
被引用次数：190 相关文章

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment.

ET Piperaki, LS Tzouvelekis, V Miriagou… - … and Infection: the …, 2019 - europepmc.org
Background Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained global
notoriety as a critically important nosocomial pathogen. It mostly affects debilitated patients …

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment.

ET Piperaki, LS Tzouvelekis, V Miriagou, GL Daikos - 2019 - cabidigitallibrary.org
Abstract Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained
global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated …
[HTML] clinicalmicrobiologyandinfection.com

[HTML][HTML] Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment

ET Piperaki, LS Tzouvelekis… - Clinical …, 2019 - clinicalmicrobiologyandinfection …
Abstract Background Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained
global notoriety as a critically important nosocomial pathogen. It mostly affects debilitated …

Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment

ET Piperaki, LS Tzouvelekis… - … and infection: the …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Carbapenem-resistant Acinetobacter baumannii (CRAB) has gained global
notoriety as a critically important nosocomial pathogen. It mostly affects debilitated patients …